We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

131 hedge funds and large institutions have $553M invested in Intra-Cellular Therapies Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 33

59% more call options, than puts

Call options by funds: $10.7M | Put options by funds: $6.7M

4% less funds holding

Funds holding: 137131 (-6)

14% less capital invested

Capital invested by funds: $643M → $553M (-$89.9M)

23% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 26

Holders
131
Holders Change
-6
Holders Change %
-4.38%
% of All Funds
2.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
54
Reduced
33
Closed
26
Calls
$10.7M
Puts
$6.7M
Net Calls
+$3.98M
Net Calls Change
+$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
HT
151
HAP Trading
New York
-$236K -14,966 Closed
OAC
152
OMERS Administration Corp
Ontario, Canada
-$227K -14,400 Closed
SG Americas Securities
153
SG Americas Securities
New York
-$190K -12,060 Closed
TRCT
154
Tower Research Capital (TRC)
New York
-$65K -4,091 Closed
PHK
155
Point72 Hong Kong
Hong Kong
-$15K -978 Closed
SBL
156
Sargent Bickham Lagudis
Colorado
-$3K -197 Closed
PNC Financial Services Group
157
PNC Financial Services Group
Pennsylvania
+$1.02K +66 New